Edition:
United States

BIOLASE Inc (BIOL.O)

BIOL.O on Consolidated Issue listed on NASDAQ Capital Market

0.61USD
22 Sep 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.61
Open
$0.56
Day's High
$0.62
Day's Low
$0.55
Volume
157,581
Avg. Vol
116,789
52-wk High
$1.98
52-wk Low
$0.48

Latest Key Developments (Source: Significant Developments)

BIOLASE names Jonathan T. Lord chairman of the board
Tuesday, 5 Sep 2017 06:00am EDT 

Sept 5 (Reuters) - Biolase Inc :BIOLASE Inc - ‍announced that on September 1, named Jonathan T. Lord, as its new chairman of board​.BIOLASE Inc - ‍Lord replaces outgoing chairman Paul N. Clark​.  Full Article

BIOLASE Q2 loss per share $0.06
Monday, 7 Aug 2017 04:05pm EDT 

Aug 7 (Reuters) - BIOLASE Inc :BIOLASE reports 2017 second quarter and six-month results.Q2 loss per share $0.06.Q2 revenue $12.6 million versus $13.8 million.  Full Article

Biolase Inc files for resale of up to 12 million shares
Friday, 21 Jul 2017 04:21pm EDT 

July 21 (Reuters) - Biolase Inc :Biolase Inc files for resale of up to 12.0 million shares of co's common stock by the selling stockholders - SEC filing.Biolase says will receive no proceeds from any sale by selling stockholders of shares of co's common stock.  Full Article

BIOLASE Q1 loss per share $0.06
Wednesday, 3 May 2017 04:05pm EDT 

May 3 (Reuters) - BIOLASE Inc ::BIOLASE reports 2017 first quarter results.Q1 loss per share $0.06.Q1 revenue fell 1 percent to $10.9 million.  Full Article

Biolase to raise $10.5 mln from institutional and individual investors in a private placement
Thursday, 13 Apr 2017 06:00am EDT 

Biolase Inc : Biolase to raise $10.5 million from institutional and individual investors in a private placement . Biolase - As per private placement, co agreed to sell 80,644 shares of a newly created series of convertible preferred stock at per share price of $124.00 .Biolase Inc - Proceeds will be used for working capital, including but not limited to new product development, launch and subsequent scale-up.  Full Article

Biolase Q4 loss per share $0.07
Wednesday, 8 Mar 2017 04:05pm EST 

Biolase Inc : Biolase reports 2016 full year and fourth quarter results . Q4 revenue fell 5 percent to $13.8 million . Q4 loss per share $0.07 .Biolase Inc says net revenue for Q4 of 2016 was $13.8 million, as compared to net revenue of $14.5 million for Q4 of 2015.  Full Article

BIOLASE announces management change
Monday, 9 Jan 2017 06:00am EST 

BIOLASE Inc : BIOLASE announces management change . BIOLASE Inc - senior vice president and chief financial officer David C. Dreyer has decided to resign effective January 13, 2017 . BIOLASE Inc - company is conducting a search for a new chief financial officer .BIOLASE - until replacement is named, dreyer's day to day finance responsibilities will be handled by Harold C. Flynn, Jr..  Full Article

Biolase files for resale of up to 10.9 mln shares by selling stockholders
Thursday, 27 Oct 2016 04:05pm EDT 

Biolase Inc : Files for resale of up to 10.9 million shares of co's common stock, by the selling stockholders - SEC filing Source: http://bit.ly/2e1V784 Further company coverage: [BIOL.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Biolase Q2 loss per share $0.06
Monday, 1 Aug 2016 06:10am EDT 

Biolase Inc : Biolase Reports 2016 Second Quarter And Six-Month results . Q2 revenue rose 16 percent to $13.8 million .Q2 loss per share $0.06.  Full Article

Biolase to raise $10 mln in convertible preferred private placement
Monday, 1 Aug 2016 06:00am EDT 

Biolase Inc : Biolase to raise $10 million from institutional and individual investors in convertible preferred private placement .Has agreed to sell an aggregate of 88,494 shares of its convertible preferred stock at a per share price of $113.00.  Full Article

BRIEF-BIOLASE names Jonathan T. Lord chairman of the board

* BIOLASE Inc - ‍announced that on September 1, named Jonathan T. Lord, as its new chairman of board​